AbbVie Inc. (ALGN) Stock Price Today — Live Chart and Analysis

Skyrizi and Rinvoq are growing fast enough to offset Humira biosimilar erosion. Botox revenue came via the 2020 Allergan acquisition. Dividend raised for 52 consecutive years.

Buy price

262.62

Sell price

262.43

Market Cap

119.76 B

AbbVie Inc. chart

Price Performance

Information regarding past performance is not a reliable indicator of future performance.

AbbVie Inc. ALGN Profile

  • Sector Health Care
  • Industry Biotechnology
  • Country United States
  • Founded 2013
  • ISIN US00287Y1091
  • CEO Robert Michael
  • abbvie.com

Analysis

Q2 2026 net revenues were $16.99 billion, up 10.2%. Adjusted EPS of $3.65 grew 22.9%. Skyrizi and Rinvoq grew 24%. Apogee Therapeutics acquisition announced for $10.9 billion. Full-year adjusted EPS guidance $13.87–$14.07. Dividend yield 3.2%.

How can I buy AbbVie Inc.?

  • 1

    Sign up

    Create an account and complete a quick verification.

  • 2

    Deposit funds

    Add money to your wallet via card, bank transfer, or crypto.

  • 3

    Trade

    Choose ALGN, set the amount, and click buy or sell — that’s it!

AbbVie Inc.

ALGN

262.525

Instrument CFD

Top gainers

Top losers

FAQ

Everything you need to know